How many drugs treat Complex dyslipidemia?

Drug Landscape tracks 3 marketed treatments for Complex dyslipidemia (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/complex-dyslipidemia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Complex dyslipidemia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Complex dyslipidemia (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Complex dyslipidemia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Praluent	ALIROCUMAB	Sanofi	PCSK9 Inhibitor [EPC]	Proprotein convertase subtilisin/kexin type 9	2015-01-01
Repatha	EVOLOCUMAB	Repatha	PCSK9 Inhibitor [EPC]	PCSK9	2015-01-01
Praluent	Praluent	Regeneron Pharmaceuticals		Proprotein convertase subtilisin/kexin type 9

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Regeneron Pharmaceuticals · 1 drug in Complex dyslipidemia
Repatha · 1 drug in Complex dyslipidemia
Sanofi · 1 drug in Complex dyslipidemia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Complex dyslipidemia:

Cite this brief

Drug Landscape (2026). Complex dyslipidemia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/complex-dyslipidemia. Accessed 2026-06-10.

Complex dyslipidemia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing